Close

Anti-SERPINF2 DNA-encoded mAb (DMAb), pVAX1 (DMAb-0852-YY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-SERPINF2 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • SERPINF2
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.

Target

  • Entrez Gene ID
  • 5345
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0852-YY CBYY-I0956 Mouse Mouse
DMAb-2234-CQ CBXS-5609 Mouse IgG2 Human recombinant Serpin-F2
DMAb-2235-CQ CBXS-5752 Mouse IgG1 Recombinant Human SerpinF2 protein
DMAb-2236-CQ CBXS-3678 Rabbit IgG Recombinant Mouse SerpinF2 protein
DMAb-2237-CQ CBXS-4655 Rat IgG2 Mouse recombinant protein of Serpin F2
DMAb-2238-CQ CBXS-4701 Rabbit IgG Recombinant Human SerpinF2 protein
DMAb-2239-CQ CBXS-0259 Mouse IgG2a
DMAb-2240-CQ CBXS-0260 Mouse IgG1
DMAb-2241-CQ CBXS-0261 Mouse Alpha-2-Plasmin Inhibitor
DMAb-2242-CQ CBXS-1048 Rabbit IgG Recombinant Human SerpinF2 Protein
DMAb-2243-CQ CBXS-1064 Rabbit IgG Recombinant Human SerpinF2 Protein
DMAb-2244-CQ CBXS-1105 Rabbit IgG Recombinant Human SerpinF2 Protein
DMAb-2245-CQ CBXS-1121 Rabbit IgG Recombinant Human SerpinF2 protein
DMAb-2246-CQ CBXS-1130 Rabbit IgG Recombinant Human SerpinF2 protein
DMAb-2247-CQ CBXS-1149 Mouse IgG1 Recombinant Human SerpinF2 Protein
DMAb-2248-CQ CBXS-1700 Rat IgG2b NS0-derived recombinant mouse Serpin F2/alpha 2-Antiplasmin, Val28-Lys491, Accession # Q61247
DMAb-2249-CQ CBXS-1715 Mouse IgG2a NS0-derived recombinant human Serpin F2/alpha 2-Antiplasmin, Met28-Lys491, Accession # P08697
DMAb-2250-CQ CBXS-2571 Rat IgG2 Recombinant protein corresponding to mouse Serpin F2
DMAb-2251-CQ CBXS-2572 Mouse IgG2 Recombinant protein corresponding to human Serpin-F2

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-SERPINF2 DNA-encoded mAb (DMAb), pVAX1 (DMAb-0852-YY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.